AMN Healthcare Services, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 29, 2010, details the completion of AMN Healthcare Services, Inc.'s (AMN) acquisition of NF Investors, Inc. (NFI), the parent company of Nursefinders, Inc. (dba Medfinders). The merger was consummated on September 1, 2010. The filing also discloses significant amendments to AMN's credit facilities and the issuance of new equity securities to facilitate the transaction.
Key Financial Metrics and Capital Structure
The filing does not provide historical revenue, profit, or cash flow metrics for AMN or NFI. Financial data is limited to the terms of the acquisition consideration and new debt instruments:
- Acquisition Consideration: NFI stockholders received 6,300,000 shares of AMN common stock and 5,432,570.9 shares of Series A Conditional Convertible Preferred Stock. This represents approximately 26% of AMN's issued and outstanding capital stock (on an as-converted basis).
- Escrow Arrangements: Approximately $16,000,000 worth of Preferred Stock was placed in escrow for indemnification claims, and $3,000,000 worth for purchase price adjustments.
- First Lien Credit Facility Amendment:
- Tranche B term loan increased by $77,750,000 to a total of $185,000,000.
- Revolver capacity remains at $40,000,000 (unused fee 0.75% per annum).
- Interest spreads: 5.50% over LIBOR or 4.50% over Prime.
- Maturity extended to August 31, 2014 (Revolver) and June 23, 2015 (Term Loan).
- Second Lien Credit Facility:
- New $40,000,000 term loan facility fully drawn.
- Interest spreads: 10.00% over LIBOR or 9.00% over Prime.
- Maturity date: September 1, 2016.
- Preferred Stock Terms: Accrues dividends at 11.00% per annum until stockholder approval of conversion. Liquidation preference is $10.00 per share plus accrued dividends.
Material Changes and Transactions
The primary material change is the acquisition of Medfinders, a leading provider of clinical workforce managed services. To fund the transaction and repay NFI's outstanding indebtedness, AMN executed the following:
- Increased its Tranche B term loan by $77,750,000.
- Incurred a new $40,000,000 Second Lien term loan.
- Issued significant equity (common and preferred stock) representing a 26% dilution to existing shareholders.
- Assumed certain NFI obligations, including a $2,500,000 transaction fee and a $916,667 management fee, paid via Preferred Stock issuance and cash.
Guidance, Risks, and Contingencies
Stockholder Approval Requirement: The conversion of the Series A Preferred Stock into common stock and the granting of voting rights are contingent upon AMN stockholder approval. If not approved within 180 days, the 11% dividend rate continues. If not approved by the tenth anniversary, AMN may redeem the stock.
Financial Covenants: The amended credit agreements impose new financial covenants, including a Minimum Liquidity covenant and Consolidated First Lien Leverage Ratio. The Second Lien agreement requires a maximum Consolidated Leverage Ratio and a minimum Consolidated Fixed Charge Coverage Ratio.
Board Composition: Two new directors, Wyche H. Walton and Martin Chavez, were appointed to the AMN board. Their continued service is contingent on their respective affiliates (HWP Capital Partners and GSUIG) maintaining specific ownership thresholds (5% and 10% respectively).
Unregistered Securities: The issuance of common stock, Preferred Stock, RSUs, and SARs was made under Section 4(2) exemptions and has not been registered under the Securities Act.
Investor Verification Checklist
- Verify the status of the pending stockholder vote required to convert the Series A Preferred Stock and forgive the 11% accrued dividends.
- Review the upcoming Form 10-Q (due within 71 days) for the required pro forma financial information and audited financial statements of NFI.
- Monitor AMN's ability to meet the new Minimum Liquidity and Leverage Ratio covenants under the amended First and Second Lien Credit Agreements.
- Assess the impact of the 26% equity dilution on existing shareholders' ownership percentage.
- Confirm the release timeline for the $19,000,000 in escrowed Preferred Stock based on indemnification and purchase price adjustments.